美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Leverage Shares 2X Long ENTG Daily ETF

9.07

-0.6395-6.58%

成交量：4,442

成交额：3.92万

市值：22.69万

市盈率：- -

高：9.22

开：9.22

低：8.61

收：9.71

52周最高：14.51

52周最低：4.60

股本：2.50万

流通股本：2.50万

量比：0.77

换手率：17.77%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

德银公布四季度科技股首选名单：Meta、Shopify、ServiceNow等9股入选，AI投资逻辑正在生变

老虎资讯综合

更多创新药有望纳入医保报销

创新生物制剂落地中国！双适应症惠及重度哮喘与鼻息肉患者

泰适卓®双适应症在华上市，为重度哮喘、慢性鼻窦炎伴鼻息肉患者提供生物制剂创新治疗选择

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/ENTL"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENTL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENTL\",,,,,undefined,":{"symbol":"ENTL","market":"US","secType":"STK","nameCN":"Leverage Shares 2X Long ENTG Daily ETF","latestPrice":9.0745,"timestamp":1791835200000,"preClose":9.714,"halted":0,"volume":4442,"delay":0,"changeRate":-0.06583281861231212,"floatShares":25000,"shares":25000,"eps":0,"marketStatus":"未开盘","change":-0.6395,"latestTime":"10-12 16:00:00 EDT","open":9.22,"high":9.22,"low":8.605,"amount":39190,"amplitude":0.063311,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1422507600000,"exchange":"CBOE","adjPreClose":9.714,"nav":9.7,"aum":242500,"bidAskSpread":0,"volumeRatio":0.769098},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENTL\",,,,,undefined,":{"symbol":"ENTL","floatShares":25000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.769098,"shares":25000,"dividePrice":0,"high":9.22,"amplitude":0.063311,"preClose":9.714,"low":8.605,"week52Low":4.6027,"pbRate":"--","week52High":14.5091,"institutionHeld":0,"latestPrice":9.0745,"eps":0,"divideRate":0,"volume":4442,"delay":0,"ttmEps":0,"open":9.22,"prevYearClose":12.45,"prevWeekClose":9.714,"prevMonthClose":8.4449,"prevQuarterClose":8.4449,"fiveDayClose":9.84,"twentyDayClose":5.9594,"sixtyDayClose":7.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENTL\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENTL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENTL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENTL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134563158","title":"德银公布四季度科技股首选名单：Meta、Shopify、ServiceNow等9股入选，AI投资逻辑正在生变","url":"https://stock-news.laohu8.com/highlight/detail?id=1134563158","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134563158?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 22:55","pubTimestamp":1790866537,"startTime":"0","endTime":"0","summary":"与此同时，Shopify自有AI助手Sidekick也被德银视为市场尚未充分定价的潜在催化剂。ServiceNow：企业AI落地带动软件升级需求经历此前软件股承压后，德银同时将ServiceNow列入重点关注名单。相比此前集中买入英伟达等AI龙头，新的投资逻辑开始沿产业链向数据中心容量、光通信、EDA软件、半导体材料等“瓶颈环节”扩散；与此同时，Meta、Shopify和ServiceNow等已经具备AI变现能力的平台公司也受到更多关注。","market":"us","thumbnail":"https://community-static.tradeup.com/news/2592c59fccbd57071636956d08e4d09d","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/2592c59fccbd57071636956d08e4d09d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德银公布四季度科技股首选名单：Meta、Shopify、ServiceNow等9股入选，AI投资逻辑正在生变","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBY","NOWL","NOW","SHPD","DLR","FBYY","FBX","METD","SHPU","LITU","FBL","LITX","SHOP","LITG","NOWX","METG","LITC","CDNS","METU","META","COMP","METQ","ENTG","LITE","SIRI","ENTL","CDNG","METW","LITZ"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2664383252","title":"更多创新药有望纳入医保报销","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383252","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383252?lang=zh_cn&edition=fundamental","pubTime":"2026-09-04 10:20","pubTimestamp":1788488426,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","MEDX","BK4585","06978","LNGR","BK1574","ENTL","HART","IHI","159992","BK4588","PSCH","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484381","title":"创新生物制剂落地中国！双适应症惠及重度哮喘与鼻息肉患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484381","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484381?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 18:40","pubTimestamp":1786963204,"startTime":"0","endTime":"0","summary":"今天，阿斯利康宣布，泰适卓?（英文商品名：Tezspire?，通用名：特泽利尤单抗注射液）在中国正式获批上市。依托两项关键III期临床研究的积极成果，该药物在国内斩获双重适应症，可用于成人及12岁以上青少年重度哮喘的维持治疗，同时能够联合鼻用糖皮质激素，治疗经系统性糖皮质激素、手术治疗后仍无法有效控制病情的慢性鼻窦炎伴鼻息肉成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843332125.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843332125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TSLQ","07366","TLA","TSLP","09366","CRSH","TSLR","TSYY","TSL","09766","TSLI","TSLG","TESL","ELOL","TSLS","ENTL","TEST","TSLW","TSLZ","07766","TSLT","TSDD","TSLL","TSII","TSLO","TSLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660334481","title":"泰适卓®双适应症在华上市，为重度哮喘、慢性鼻窦炎伴鼻息肉患者提供生物制剂创新治疗选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2660334481","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660334481?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 16:21","pubTimestamp":1786954860,"startTime":"0","endTime":"0","summary":"特泽利尤单抗的上市，为慢性鼻窦炎伴鼻息肉患者带来了新的治疗选择，有望帮助他们实现长期疾病控制，改善生活质量。携双适应症在华上市，特泽利尤单抗有望充分释放上游炎症通路靶点的临床价值，进一步完善我们在哮喘领域从轻中度到重度的全病程疾病管理布局，加速哮喘治疗迈向'临床治愈'愿景，同时满足广大慢性鼻窦炎伴鼻息肉患者的未尽之需。其中，高达10%的哮喘患者为重度哮喘22,23。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5027377_ZH27377_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5027377_ZH27377_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1829250122.USD","LU2456880835.USD","LU2237443622.USD","LU2417539215.USD","LU0708994859.HKD","LU0109394709.USD","AZN","LU2089984988.USD","LU2237443382.USD","LU2236285917.USD","LU2462157665.USD","LU1267930573.SGD","IPOS","LU2468319806.SGD","LU2237443549.SGD","BK4007","BK4588","LU0058720904.USD","LU0310800379.SGD","AZNH","LU0289739699.SGD","LU0432979614.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0320765992.SGD","LU0128525929.USD","LU0029864427.USD","BK4585","BK4568","ENTL","LU2237443465.HKD","LU2237443895.HKD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ENTL\",params:#limit:6,delay:false,,,undefined,":[]}}